bullish

EQT/​Dechra Pharmaceuticals: Recommended Offer

Jesus has highlighted this Insight as a Top Pick
556 Views02 Jun 2023 19:54
In spite of negative trading updated, EQT has followed in its pursuit of Dechra and today both have agreed a fair, in my view, 3,875p/share offer (21.4x EV/Fwd EBITDA, 30.2x Fwd P/E).
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Top Quartile
Jesus Rodriguez Aguilar
European Event-Driven Analyst
Multi-AssetEvent-Driven
Price Chart(Sign Up to Access)
analytics-chart
x